Sellas Life Sciences Group Inc banner

Sellas Life Sciences Group Inc
NASDAQ:SLS

Watchlist Manager
Sellas Life Sciences Group Inc Logo
Sellas Life Sciences Group Inc
NASDAQ:SLS
Watchlist
Price: 4.21 USD -0.47%
Market Cap: $755.9m

Wall Street
Price Targets

SLS Price Targets Summary
Sellas Life Sciences Group Inc

Wall Street analysts forecast SLS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SLS is 8.84 USD with a low forecast of 6.06 USD and a high forecast of 10.5 USD.

Lowest
Price Target
6.06 USD
44% Upside
Average
Price Target
8.84 USD
110% Upside
Highest
Price Target
10.5 USD
149% Upside
Sellas Life Sciences Group Inc Competitors:
Price Targets
ACIU
AC Immune SA
235% Upside
VAC
Pierre et Vacances SA
38% Upside
CASY
Caseys General Stores Inc
0% Downside
KNSA
Kiniksa Pharmaceuticals Ltd
18% Upside

Revenue
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-100%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-100%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is SLS's stock price target?
Price Target
8.84 USD

According to Wall Street analysts, the average 1-year price target for SLS is 8.84 USD with a low forecast of 6.06 USD and a high forecast of 10.5 USD.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett